Microalgal compounds modulate carcinogenesis in the gastrointestinal tract

Trends in Biotechnology

Volumn 31, Issue 2, 2013, Pages 92-98

  Amaro, Helena M ^a,b   Barros, Rita ^b   Guedes, A Catarina ^a   Sousa Pinto, I ^a,b   Malcata, F Xavier ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMORS; ANTIBACTERIAL COMPOUNDS; CHEMOPREVENTIVE; GASTRIC CANCERS; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; MICRO-ALGAE; SULFATED POLYSACCHARIDES;

ALGAE; MICROORGANISMS; PATHOLOGY; PIGMENTS; POLYSACCHARIDES; POLYUNSATURATED FATTY ACIDS;

DISEASES;

ANTIBIOTIC AGENT; ASTAXANTHIN; CAROTENOID; D GALACTAN SULFATE; DNA TOPOISOMERASE; FLAVONOID; FUCOXANTHIN; PHENOL; POLYSACCHARIDE SULFATE; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VIOLAXANTHIN;

ALGA; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BIOSYNTHESIS; CANCER MORTALITY; CANCER PREVENTION; CAUSE OF DEATH; CHAETOSEROS; CHLORELLA ELLIPSOIDEA; CHLORELLA VULGARIS; DIGESTIVE SYSTEM CANCER; GASTROINTESTINAL TRACT; GYMNODINIUM; HAEMATOCOCCUS PLUVIALIS; HELICOBACTER INFECTION; HUMAN; ISOCHRISYS; MICROALGA; NONHUMAN; ODONTELLA AURITA; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BACTERIAL ADHESION; CAROTENOIDS; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; MICROALGAE; PLANT PROTEINS; POLYSACCHARIDES; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 84872788447     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.11.004     Document Type: Review

References (75)

1. Guedes A.C., et al. Microalgae as sources of high added-value compounds - a brief review of recent work. Biotechnol. Prog. 2011, 27:597-613.
2. Olaizola M. Commercial development of microalgal biotechnology: from the test tube to the marketplace. Biomol. Eng. 2003, 20:459-466.
3. Newman D.J., Cragg G.M. Natural products from marine invertebrates and microbes as modulators of antitumor targets. Curr. Drug Targets 2006, 7:279-304.
4. Ferlay J., et al. Globocan 2008, Cancer Incidence and Mortality Worldwide 2008, International Agency for Research on Cancer (IARC).
5. Russo M., et al. Dietary phytochemicals in chemoprevention of cancer. Curr. Med. Chem. Immunol. Endocr. Metab. Agents 2005, 5:61-72.
6. Yang C.S., et al. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 2001, 21:381-406.
7. Kanadaswami C., et al. The antitumor activities of flavonoids. In Vivo 2005, 19:895-909.
8. Xiao B., et al. Aloe-emodin induces in vitro G2/M arrest and alkaline phosphatase activation in human oral cancer KB cells. Oral Oncol. 2007, 43:905-910.
9. Lee Y.G., et al. Induction of apoptosis in a human lymphoma cell line by hydrophobic peptide fraction separated from anchovy sauce. Biofactors 2004, 21:63-67.
10. Tzianabos A.O. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biological function. Clin. Microbiol. Rev. 2000, 13:523-533.
11. Sheih I.C., et al. Anticancer and antioxidant activities of the peptide fraction from algae protein waste. J. Agric. Food Chem. 2009, 58:1202-1207.
12. Mohd-Azamai E., et al. Chlorella vulgaris triggers apoptosis in hepatocarcinogenesis-induced rats. J. Zhejiang Univ. Sci. B 2009, 10:14-21.
13. Chinery R., et al. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBP[b]. Nat. Med. 1997, 3:1233-1241.
14. Fleischauer A.T., et al. Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women. Nutr. Cancer 2003, 46:15-22.
15. Palozza P., et al. Modulation of apoptotic signalling by carotenoids in cancer cells. Arch. Biochem. Biophys. 2004, 430:104-109.
16. Palozza P., et al. β-Carotene downregulates the steady-state and heregulin-α-induced COX-2 pathways in colon cancer cells. J. Nutr. 2005, 135:129-136.
17. Umemura K., et al. Inhibition of DNA topoisomerases I and II, and growth inhibition of human cancer cell lines by a marine microalgal polysaccharide. Biochem. Pharm. 2003, 66:481-487.
18. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 2001, 70:369-413.
19. Ip P-F., Chen F. Production of astaxanthin by the green microalga Chlorella zofingiensis in the dark. Proc. Biochem. 2005, 40:733-738.
20. Palozza P., et al. Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells. Cancer Lett. 2009, 283:108-117.
21. Lee B.J., et al. S2043 Anticancer effects of astaxanthin in stomach cancer cell lines. Gastroenterology 2009, 136:A-A319.
22. Jyonouchi H., et al. Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr. Cancer 1994, 21:47-58.
23. Klippel K.F., et al. A multicentric, placebo-controlled, double-blind clinical trial of β-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. Br. J. Urol. 1997, 80:427-432.
24. Gerber G.B., et al. Carcinogenicity, mutagenicity and teratogenicity of manganese compounds. Crit. Rev. Oncol. Hematol. 2002, 42:25-34.
25. Mazhar D., et al. COX inhibitors and breast cancer. Br. J. Cancer 2006, 94:346-350.
26. Gilmore T.D. Introduction to NF-κB: players, pathways, perspectives. Oncogene 2006, 25:6680-6684.
27. Tanaka T., et al. Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls, astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis 1995, 16:2957-2963.
28. Tanaka T., et al. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 1995, 55:4059-4064.
29. Prabhu P.N., et al. Antioxidative and antiproliferative effects of astaxanthin during the initiation stages of 1,2-dimethyl hydrazine-induced experimental colon carcinogenesis. Fundam. Clin. Pharmacol. 2009, 23:225-234.
30. Kurihara H., et al. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci. 2002, 70:2509-2520.
31. 4-treated rats. Methods Find. Exp. Clin. Pharmacol. 2001, 23:79-84.
32. Margalith P.Z. Production of ketocarotenoids by microalgae. Appl. Microbiol. Biotechnol. 1999, 51:431-438.
33. Tran N-P., et al. Proteomics of proteins associated with astaxanthin accumulation in the green algae Haematococcus lacustris under the influence of sodium orthovanadate. Biotechnol. Lett. 2009, 31:1917-1922.
34. Zhang D., Lee Y. Enhanced accumulation of secondary carotenoids in a mutant of the green alga, Chlorococcum sp. J. Appl. Phycol. 1997, 9:459-463.
35. Gouveia L., et al. Use of Chlorella vulgaris as a carotenoid source for rainbow trout: effect of dietary lipid content on pigmentation, digestibility and retention in the muscle tissue. Aquacult. Int. 1998, 6:269-279.
36. Siddiq A., Dembitsky V. Acetylenic anticancer agents. Anticancer Agents Med. Chem. 2008, 8:132-170.
37. Dembitsky V. Anticancer activity of natural and synthetic acetylenic lipids. Lipids 2006, 41:883-924.
38. Hartmann R., Meisel H. Food-derived peptides with biological activity: from research to food applications. Curr. Opin. Biotechnol. 2007, 18:163-169.
39. Watkins S.M., et al. Docosahexaenoic acid accumulates in cardiolipin and enhances HT-29 cell oxidant production. J. Lipid Res. 1998, 39:1583-1588.
40. McMillin J.B., Dowhan W. Cardiolipin and apoptosis. Biochim. Biophys. Acta 2002, 1585:97-107.
41. Starkov A.A., et al. Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. J. Neurochem. 2002, 83:220-228.
42. 2+-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry 1999, 38:13279-13287.
43. Belikova N.A., et al. Cardiolipin-specific peroxidase reactions of cytochrome c in mitochondria during irradiation-induced apoptosis. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:176-186.
44. Paradies G., et al. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic. Biol. Med. 1999, 27:42-50.
45. Jemmerson R., et al. A conformational change in cytochrome c of apoptotic and necrotic cells is detected by monoclonal antibody binding and mimicked by association of the native antigen with synthetic phospholipid vesicles. Biochemistry 1999, 38:3599-3609.
46. Lee S.E., et al. Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. Ann. N. Y. Acad. Sci. 2009, 1171:163-169.
47. Albino A.P., et al. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Cancer Res. 2000, 60:4139-4145.
48. Wu J-C., et al. Effect of combination of docosahexaenoic acid and fluorouracil on human gastric carcinoma cell strain MGC803. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2010, 32:65-70.
49. Coleman G., et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann. Oncol. 2003, 14:v128-v149.
50. Liu B.H., Lee Y.K. Effect of total secondary carotenoids extracts from Chlorococcum sp. on Helicobacter pylori-infected BALB/c mice. Int. Immunopharmacol. 2003, 3:979-986.
51. Perez-Perez G.I., et al. Epidemiology of Helicobacter pylori infection. Helicobacter 2004, 9:1-6.
52. Bauer B., Meyer T.F. The human gastric pathogen Helicobacter pylori and its association with gastric cancer and ulcer disease. Ulcers 2011, 10.1155/2011/340157.
53. Shimizu T., et al. Helicobacter pylori and the surface mucous gel layer of the human stomach. Helicobacter 1996, 1:207-218.
54. van de Bovenkamp J., et al. The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach. Helicobacter 2003, 8:521-532.
55. Bavington C., Page C. Stopping bacterial adhesion: a novel approach to treating infections. Respiration 2005, 72:335-344.
56. Loke M.F., et al. Antiadhesive property of microalgal polysaccharide extract on the binding of Helicobacter pylori to gastric mucin. FEMS Immunol. Med. Microbiol. 2007, 50:231-238.
57. Bennedsen M., et al. Treatment of H. pylori-infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol. Lett. 2000, 70:185-189.
58. Akyön Y. Effect of antioxidants on the immune response of Helicobacter pylori. Clin. Microbiol. Infect. 2002, 8:438-441.
59. Saldinger P.F., et al. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 1998, 115:891-897.
60. Kupcinskas L., et al. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: a prospective, randomized, double blind, and placebo-controlled study. Phytomedicine 2008, 15:391-399.
61. Correa P., et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J. Natl. Cancer Inst. 2000, 92:1881-1888.
62. Yuan J-P., et al. Potential health-promoting effects of astaxanth: a high-value carotenoid mostly from microalgae. Mol. Food Nutr. Res. 2011, 55:150-165.
63. Kamath B.S., et al. Ulcer preventive and antioxidative properties of astaxanthin from Haematococcus pluvialis. Eur. J. Pharmacol. 2008, 590:387-395.
64. Hussein G., et al. Astaxanthin, a carotenoid with potential in human health and nutrition. J. Nat. Prod. 2005, 69:443-449.
65. Wang X., et al. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob. Agents Chemother. 2000, 44:2452-2457.
66. Harris T., Sun T. Multifactorial etiology of human liver cancer. Carcinogenesis 1984, 5:697-701.
67. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 1990, 8:583-599.
68. Lewis T.S., et al. Signal transduction through MAP kinase cascades. Advances in Cancer Research 1998, 49-139. Academic Press. V.W. George, K. George (Eds.).
69. Xu G., et al. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 2006, 27:437-445.
70. Ameyar M., et al. A role for AP-1 in apoptosis: the case for and against. Biochimie 2003, 85:747-752.
71. Lauricella M., et al. JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways. Apoptosis 2006, 11:607-625.
72. Moreau D., et al. Cultivated microalgae and the carotenoid fucoxanthin from Odontella aurita as potent anti-proliferative agents in bronchopulmonary and epithelial cell lines. Environ. Toxicol. Pharmacol. 2006, 22:97-103.
73. Cha K.H., et al. Antiproliferative effects of carotenoids extracted from Chlorella ellipsoidea and Chlorella vulgaris on human colon cancer cells. J. Agric. Food Chem. 2008, 56:10521-10526.
74. Soontornchaiboon W., Kim S.M. Antiproliferative activities of violaxanthin extracted from microalga Chlorella ellipsoidea. 12th Asian Food Conference 2011, PC-125, p. 514.
75. Ascencio F., et al. Effectiveness of Cyanothece spp. and Cyanospira capsulata exocellular polysaccharides as antiadhesive agents for blocking attachment of Helicobacter pylori to human gastric cells. Folia Microbiol. 2004, 41:64-70.